Oseltamivir phosphate (tamiflu) 30MG and 75MG capsules
Ended Awarded Last action
- Contract number
- 75A50325F80003
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $45,106,864
Award facts
- Contract value 100% obligated
- $45,106,864.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$187 | |
| Terminate for Convenience | -$351,892,349 | |
| Original award | $396,999,400 |
About this award
Genentech USA, Inc., a foreign-owned pharmaceutical manufacturer headquartered in South San Francisco, California, received a $45.1 million delivery order from the Office of the Assistant Secretary for Preparedness and Response (ASPR) for Oseltamivir Phosphate (Tamiflu) 30mg and 75mg capsules. Awarded on January 30, 2025, with an ultimate completion date of June 6, 2025, this firm fixed-price contract utilizes no set-aside designation and is issued under Genentech's existing Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) contract vehicle. The award includes a termination for convenience agreement and closeout modification, reflecting standard government procurement practices for pharmaceutical supplies.
This delivery order supports ASPR's mission to strengthen national preparedness and response capabilities for public health emergencies by securing antiviral medications critical to pandemic response and seasonal influenza management. Tamiflu is a key therapeutic agent in the federal government's medical countermeasures strategy and stockpile initiatives. Genentech's established relationship with ASPR and other federal agencies, combined with its substantial GSA Schedule contract and proven track record supplying specialized pharmaceuticals to the Department of Veterans Affairs, Defense Logistics Agency, and other government entities, positions the company as a reliable source for this critical medical supply procurement.
Quick answers
Who was awarded contract 75A50325F80003?
75A50325F80003 was awarded to Genentech Usa, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on January 30, 2025.
How much is contract 75A50325F80003 worth?
The government has obligated $45,106,864 on 75A50325F80003.
Is contract 75A50325F80003 an order under another contract?
Yes. 75A50325F80003 is a delivery order under 36F79723D0219, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75A50325F80003 competed?
The extent of competition for 75A50325F80003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award